ARWR Covered Call Strategy
ARWR (Arrowhead Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Arrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challenging-to-treat diseases within the United States. The company's extensive therapeutic pipeline primarily leverages RNA interference (RNAi) technology. Among its advanced clinical programs are: ARO-AAT, a Phase II therapeutic targeting liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is undergoing both Phase 2b and Phase 3 clinical evaluations for hypertriglyceridemia; ARO-ANG3, currently in Phase 2b development to reduce the production of angiopoietin-like protein 3; and ARO-HIF2, a Phase 1b candidate designed to treat clear cell renal cell carcinoma. Arrowhead also has several compounds in earlier clinical development, including ARO-HSD in Phase 1/2a for other liver diseases, ARO-ENaC in Phase 1/2a, aimed at decreasing the epithelial sodium channel alpha subunit in lung airways, and ARO-C3, also in Phase 1/2a, for complement-mediated diseases. Further expanding its diverse portfolio, the company is actively developing ARO-Lung2 for chronic obstructive pulmonary disorder (COPD), ARO-DUX4 for facioscapulohumeral muscular dystrophy, ARO-XDH for uncontrolled gout, and ARO-COV for COVID-19 and other pulmonary-borne pathogens. Beyond its core internal programs, Arrowhead is involved in the progression of JNJ-3989, a subcutaneously administered RNAi therapeutic for chronic hepatitis B virus infection; Olpasiran, intended to reduce apolipoprotein A production; and ARO-AMG1, which targets genetically validated cardiovascular pathways.
ARWR (Arrowhead Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $11.11B, a beta of 1.28 versus the broader market, a 52-week range of 14.3-84.549, average daily share volume of 2.0M, a public-listing history dating back to 1993, approximately 609 full-time employees. These structural characteristics shape how ARWR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.28 places ARWR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a covered call on ARWR?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current ARWR snapshot
As of June 30, 2026, spot at $82.74, ATM IV 57.60%, IV rank 25.22%, expected move 16.51%. The covered call on ARWR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this covered call structure on ARWR specifically: ARWR IV at 57.60% is on the cheap side of its 1-year range, which means a premium-selling ARWR covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 16.51% (roughly $13.66 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ARWR expiries trade a higher absolute premium for lower per-day decay. Position sizing on ARWR should anchor to the underlying notional of $82.74 per share and to the trader's directional view on ARWR stock.
ARWR covered call setup
The ARWR covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ARWR near $82.74, the first option leg uses a $87.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ARWR chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ARWR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $82.74 | long |
| Sell 1 | Call | $87.50 | $1.78 |
ARWR covered call risk and reward
- Net Premium / Debit
- -$8,096.50
- Max Profit (per contract)
- $653.50
- Max Loss (per contract)
- -$8,095.50
- Breakeven(s)
- $80.97
- Risk / Reward Ratio
- 0.081
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
ARWR covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on ARWR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$8,095.50 |
| $18.30 | -77.9% | -$6,266.18 |
| $36.60 | -55.8% | -$4,436.87 |
| $54.89 | -33.7% | -$2,607.55 |
| $73.18 | -11.6% | -$778.23 |
| $91.48 | +10.6% | +$653.50 |
| $109.77 | +32.7% | +$653.50 |
| $128.06 | +54.8% | +$653.50 |
| $146.36 | +76.9% | +$653.50 |
| $164.65 | +99.0% | +$653.50 |
When traders use covered call on ARWR
Covered calls on ARWR are an income strategy run on existing ARWR stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
ARWR thesis for this covered call
The market-implied 1-standard-deviation range for ARWR extends from approximately $69.08 on the downside to $96.40 on the upside. A ARWR covered call collects premium on an existing long ARWR position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether ARWR will breach that level within the expiration window. Current ARWR IV rank near 25.22% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ARWR at 57.60%. As a Healthcare name, ARWR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ARWR-specific events.
ARWR covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ARWR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ARWR alongside the broader basket even when ARWR-specific fundamentals are unchanged. Short-premium structures like a covered call on ARWR carry tail risk when realized volatility exceeds the implied move; review historical ARWR earnings reactions and macro stress periods before sizing. Always rebuild the position from current ARWR chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on ARWR?
- A covered call on ARWR is the covered call strategy applied to ARWR (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With ARWR stock trading near $82.74, the strikes shown on this page are snapped to the nearest listed ARWR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ARWR covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the ARWR covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 57.60%), the computed maximum profit is $653.50 per contract and the computed maximum loss is -$8,095.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ARWR covered call?
- The breakeven for the ARWR covered call priced on this page is roughly $80.97 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ARWR market-implied 1-standard-deviation expected move is approximately 16.51%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on ARWR?
- Covered calls on ARWR are an income strategy run on existing ARWR stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current ARWR implied volatility affect this covered call?
- ARWR ATM IV is at 57.60% with IV rank near 25.22%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.